T7	Effect 20 54	reversible encephalopathy syndrome
T9	Age 60 71	16-year-old
T10	Gender 72 76	girl
T5	Subject 58 114	a 16-year-old girl with acute myelogenous leukemia (AML)
T11	Treat-Disorder 82 108	acute myelogenous leukemia
T13	Drug 239 249	idarubicin
T14	Drug 180 185	BH-AC
T15	Treatment 141 249	consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin
T8	Adverse_event 123 133	undergoing
T12	Combination 235 238	and
E1	Adverse_event:T8 
E2	Combination:T12 arg:T13 arg2:T14